Simplifying Global Compliance
View Archived Issues
Dec. 17, 2018
Vol. 17
No. 243
Headlines
Full Issue of Drug Industry Daily
View the entire issue. Read More
Senators Introduce Bill to End ‘Predatory’ Pricing of Life-Saving Drugs
Four democratic senators introduced legislation aimed at ending “predatory” pricing of insulin and other life-saving drugs. The bill would give HHS authority to block any price increases on drugs that it deems “unjustified.” Read More
Kaléo Promises Generic Naloxone Injector After Blistering Senate Pricing Report
A month after a scathing congressional report hit Kaléo for hiking prices for its opioid antidote by 600 percent, the company announced it will release a lower-cost generic version of its auto-injector in 2019. Read More
CHMP Recommends Seven Drugs for Approval at December Meeting
The EMA’s Committee for Medicinal Products for Human Use recommended seven medicines at its Dec. 10-13 meeting for approval by the European Commission. Read More
Indian Drugmaker Warned After Refusing FDA Inspection
Indian drug manufacturer SkyLark CMC drew a warning letter from the FDA by denying the agency investigator access to its manufacturing facility in Ahmedabad, Gujarat. Read More
